Sign in Subscribe
Pregnant women

Cupid Secures CE Certification for IVD Solutions, Embarks on Global Expansion

Strategic Insights

— 1 min read

Cupid, a leading Indian healthcare exporter, has marked a significant milestone in its transformation into a globally certified IVD solutions provider. The company has been granted CE (EU IVDR) Certification for two critical in-vitro diagnostic (IVD) devices, the CupiSURE Pregnancy (hCG) Test Kit and the CupiKIT Syphilis Antibody Test Kit. This development has tremendous implications for Cupid's expansion into the European Economic Area and other CE-recognized global markets. With a focus on high-growth diagnostic categories, Cupid is poised to capitalize on the increasing demand for accurate and reliable diagnostic solutions.

Key Takeaways:

  • Cupid has secured CE (EU IVDR) Certification for two key IVD devices, the CupiSURE Pregnancy (hCG) Test Kit and the CupiKIT Syphilis Antibody Test Kit.
  • The CE certification authorizes Cupid to distribute these kits across the European Economic Area and other CE-recognized global markets.
  • The certified IVD kits target two of the fastest-growing diagnostic categories: Pregnancy (hCG) Test Kits and Syphilis Immunoassay Diagnostics.
  • The global market for Pregnancy (hCG) Test Kits is valued at $1.7 billion in 2024 and projected to reach $2.9 billion by 2034 (CAGR around 5.4%).
  • The market for Syphilis Immunoassay Diagnostics is estimated at $611 million in 2025 and expected to grow to $993 million by 2034 (CAGR around 5.6%).
  • Cupid is in the final stages of securing CE (EU IVDR) Certification for its HIV 1 & 2 Antibody and Hepatitis B Antigen IVD kits, expected by December 2025.
  • Cupid generates revenue from the manufacturing and marketing of male and female condoms, water-based lubricant, latex dental dams, and probe covers, with a diverse product basket available in many countries worldwide.

Statistics:

  • The BSE group 'B' stock of face value Rs. 1 has touched a 52-week high of Rs. 254.45 on 17-Oct-2025 and a 52-week low of Rs. 50.00 on 07-Apr-2025.
  • The current market capitalization of Cupid is Rs. 6,789.53 crore.
  • Cupid's promoters hold 42.52% of the company, while Institutions and Non-Institutions hold 1.06% and 56.43% respectively.

Sources:

  • Cupid's financial statements and press releases.
  • "Global Market for Pregnancy (hCG) Test Kits" by CAGR.
  • "Syphilis Immunoassay Diagnostics Market" by CAGR.
  • Accord Fintech's disclaimer and terms of service.

Read more